280 related articles for article (PubMed ID: 12584342)
21. Identification of a key determinant of hepatitis C virus cell culture adaptation in domain II of NS3 helicase.
Grobler JA; Markel EJ; Fay JF; Graham DJ; Simcoe AL; Ludmerer SW; Murray EM; Migliaccio G; Flores OA
J Biol Chem; 2003 May; 278(19):16741-6. PubMed ID: 12615931
[TBL] [Abstract][Full Text] [Related]
22. Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77.
Li YP; Ramirez S; Mikkelsen L; Bukh J
J Virol; 2015 Jan; 89(1):811-23. PubMed ID: 25355880
[TBL] [Abstract][Full Text] [Related]
23. Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.
Wolfisberg R; Holmbeck K; Nielsen L; Kapoor A; Rice CM; Bukh J; Scheel TKH
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292246
[TBL] [Abstract][Full Text] [Related]
24. Replication efficiency of chimeric replicon containing NS5A-5B genes derived from HCV-infected patient sera.
Tripathi RL; Krishnan P; He Y; Middleton T; Pilot-Matias T; Chen CM; Lau DT; Lemon SM; Mo H; Kati W; Molla A
Antiviral Res; 2007 Jan; 73(1):40-9. PubMed ID: 16914212
[TBL] [Abstract][Full Text] [Related]
25.
Ng TI; Tripathi R; Reisch T; Lu L; Middleton T; Hopkins TA; Pithawalla R; Irvin M; Dekhtyar T; Krishnan P; Schnell G; Beyer J; McDaniel KF; Ma J; Wang G; Jiang LJ; Or YS; Kempf D; Pilot-Matias T; Collins C
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084747
[TBL] [Abstract][Full Text] [Related]
26. Production of infectious genotype 1b virus particles in cell culture and impairment by replication enhancing mutations.
Pietschmann T; Zayas M; Meuleman P; Long G; Appel N; Koutsoudakis G; Kallis S; Leroux-Roels G; Lohmann V; Bartenschlager R
PLoS Pathog; 2009 Jun; 5(6):e1000475. PubMed ID: 19521536
[TBL] [Abstract][Full Text] [Related]
27. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
Yu M; Corsa AC; Xu S; Peng B; Gong R; Lee YJ; Chan K; Mo H; Delaney W; Cheng G
Antiviral Res; 2013 Nov; 100(2):439-45. PubMed ID: 24013001
[TBL] [Abstract][Full Text] [Related]
28. A conserved proline between domains II and III of hepatitis C virus NS5A influences both RNA replication and virus assembly.
Hughes M; Gretton S; Shelton H; Brown DD; McCormick CJ; Angus AG; Patel AH; Griffin S; Harris M
J Virol; 2009 Oct; 83(20):10788-96. PubMed ID: 19656877
[TBL] [Abstract][Full Text] [Related]
29. Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons.
Lanford RE; Guerra B; Lee H; Averett DR; Pfeiffer B; Chavez D; Notvall L; Bigger C
J Virol; 2003 Jan; 77(2):1092-104. PubMed ID: 12502825
[TBL] [Abstract][Full Text] [Related]
30. Replication and infectivity of a novel genotype 1b hepatitis C virus clone.
Date T; Morikawa K; Tanaka Y; Tanaka-Kaneko K; Sata T; Mizokami M; Wakita T
Microbiol Immunol; 2012 May; 56(5):308-17. PubMed ID: 22320232
[TBL] [Abstract][Full Text] [Related]
31. Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system.
Li YP; Ramirez S; Jensen SB; Purcell RH; Gottwein JM; Bukh J
Proc Natl Acad Sci U S A; 2012 Nov; 109(48):19757-62. PubMed ID: 23151512
[TBL] [Abstract][Full Text] [Related]
32. Efficient rescue of hepatitis C virus RNA replication by trans-complementation with nonstructural protein 5A.
Appel N; Herian U; Bartenschlager R
J Virol; 2005 Jan; 79(2):896-909. PubMed ID: 15613318
[TBL] [Abstract][Full Text] [Related]
33. Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.
Murayama A; Sugiyama N; Suzuki R; Moriyama M; Nakamura N; Mochizuki H; Wakita T; Kato T
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928005
[TBL] [Abstract][Full Text] [Related]
34. Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon.
Shimakami T; Hijikata M; Luo H; Ma YY; Kaneko S; Shimotohno K; Murakami S
J Virol; 2004 Mar; 78(6):2738-48. PubMed ID: 14990694
[TBL] [Abstract][Full Text] [Related]
35. Trans-complementation of HCV replication by non-structural protein 5A.
Tong X; Malcolm BA
Virus Res; 2006 Feb; 115(2):122-30. PubMed ID: 16146661
[TBL] [Abstract][Full Text] [Related]
36. A genotype 2b NS5B polymerase with novel substitutions supports replication of a chimeric HCV 1b:2b replicon containing a genotype 1b NS3-5A background.
Graham DJ; Stahlhut M; Flores O; Olsen DB; Hazuda DJ; Lafemina RL; Ludmerer SW
Antiviral Res; 2006 Jan; 69(1):24-30. PubMed ID: 16297457
[TBL] [Abstract][Full Text] [Related]
37. Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs.
Krönke J; Kittler R; Buchholz F; Windisch MP; Pietschmann T; Bartenschlager R; Frese M
J Virol; 2004 Apr; 78(7):3436-46. PubMed ID: 15016866
[TBL] [Abstract][Full Text] [Related]
38. Development of robust genotype 1a hepatitis C replicons harboring adaptive mutations for facilitating the antiviral drug discovery and study of virus replication.
Lin HM; Wu PS; Hu HS; Chang WC; Wu RH; Tian JN; Chern JH; Yueh A
J Virol Methods; 2018 Sep; 259():10-17. PubMed ID: 29782889
[TBL] [Abstract][Full Text] [Related]
39. [Interferon resistance and ISDR (interferon sensitivity determining region)].
Amemiya F; Maekawa S; Enomoto N
Nihon Rinsho; 2006 Jul; 64(7):1249-53. PubMed ID: 16838640
[TBL] [Abstract][Full Text] [Related]
40. Bile acids specifically increase hepatitis C virus RNA-replication.
Chhatwal P; Bankwitz D; Gentzsch J; Frentzen A; Schult P; Lohmann V; Pietschmann T
PLoS One; 2012; 7(4):e36029. PubMed ID: 22558311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
